SELECTIVE RISK-ON / EVENT-RISK Thursday's broad U.S. advance, lower VIX/yields and positive Asian tape improve breadth, but $91 oil, elevated long rates and today's U.S. payroll report keep conviction conditional.
Generated 08:33:15 CEST (Europe/Rome) / 06:33:15 UTC. Data cutoff about 08:33 CEST. U.S./European cash values are Sep. 3 closes; Asian values are Sep. 4 latest/near-close; futures and commodities are observations around 08:22 CEST. At 08:30 Italy, European cash markets are not yet open and the August U.S. Employment Situation at 14:30 CEST has not been released.
Cash changes use adjacent daily closes. Futures/commodities compare the live observation with Yahoo's prior settlement field. Asian bars are latest available, not all final closes. Official Treasury curve is dated Sep. 3.
All four major U.S. indices rose; Nasdaq led at +1.40%, Dow gained 624 points, and VIX fell to 14.32. CNBC independently reports the major averages rose and entered Friday headed for a winning week. S&P data · CNBC live recap
CNBC cites a 53,000 consensus for August nonfarm payroll growth and 4.1% unemployment. The release is due at 08:30 ET / 14:30 CEST—six hours after publication. Rates, dollar, small caps and long-duration themes can gap on the result and revisions. CNBC preview · BLS schedule
HPE +5.04%, NVDA +1.80%, VRT +4.73% and SNOW +16.55% confirmed demand/momentum; AVGO −2.75% and CIEN −10.36% fell despite strong reported growth. AI evidence is real, but expectations dominate one-day returns. CIEN release · SNOW release
Risk class: mega-cap semiconductor, high expectations/M&A. Classification: breakout continuation. Direction remains uncertain.
Horizons: Day: long-bias only above $230.40 after payrolls. 1–4 weeks: applicable while $224.75/$220.41 hold. 3–12+ months: only after valuation, margins, FCF and $12.93B acquisition review.
Thesis/catalyst: $228.45, +1.80%; it closed above yesterday's $227.95 confirmation, on 134.0M shares versus 127.4M 20-session average. Its Q2 revenue was $46.7B and Q3 guide $54.0B ±2%; acquisition news expands platform scope.
Evidence / counterargument: close confirmed breakout and sector demand is corroborated by HPE/CIEN/AVGO. Counter: it did not close above $230.40, long rates are high, and M&A adds execution/regulatory/capital-allocation risk.
Entry/confirmation: hold $227.95 then break/close above $230.40 with semiconductor breadth after jobs. Invalidation/downside: below $224.75 weakens; close below $220.41 invalidates continuation, with $215.10 secondary support. Key risks: valuation compression, margins, China/export policy, concentration, competition, acquisition, power constraints and gaps. price/volume · results · M&A
Risk class: large-cap infrastructure; extreme event/integration volatility. Classification: earnings breakout with chase risk. Direction uncertain.
Horizons: Day: only above $54.88 after an opening range. 1–4 weeks: applicable if $51.83–$52.48 holds. 3–12+ months: only after Juniper integration, leverage, margins, valuation and FCF review.
Thesis/catalyst: $54.44, +5.04% on 72.1M shares, above both prior $52.48 and $53.16 confirmations. Official Q3 revenue was $12.2B (+34%), data-center networking +112.2% and server +35.3%; FY27 framework calls for 13–17% revenue growth and at least $5B FCF.
Evidence / counterargument: close near $54.88 high despite a $45.70 event low shows buyers recovered control. Counter: the 17% low-to-high range is unstable, integration/debt and lower-margin AI server mix matter, and the stock remains below its 20-session $63.44 high.
Entry/confirmation: no open chase; require hold above $52.48 and break $54.88 on volume. Invalidation/downside: close below $51.83 weakens; below $49.80 invalidates the breakout. Key risks: event gaps, integration, leverage, margins, supply, concentration, competition and rates. official release · price
Risk class: large-cap/high-beta AI power and cooling. Classification: technical breakout, fundamental confirmation pending. Direction uncertain.
Horizons: Day: above $270.99 only with breadth. 1–4 weeks: applicable above $260.05. 3–12+ months: not yet ranked without refreshed backlog, margin, FCF and valuation work.
Thesis/catalyst: $268.83, +4.73% on 4.24M shares, above yesterday's $260.05/$261.79 triggers and modestly above its 4.02M 20-session average. AI network/server results support data-center infrastructure demand.
Evidence / counterargument: close was near the $270.99 high. Counter: no fresh company-specific catalyst was verified, the stock remains below its $300.30 20-session high, and power/permitting bottlenecks can delay deployments.
Entry/confirmation: hold $261.79 and close above $270.99. Invalidation/downside: below $260.05 weakens; close below $254.50 invalidates, with $248.75 reference. Key risks: valuation, capex timing, execution, competition, input costs, power/permitting, rates and gaps. price/volume · network-demand read-through
Risk class: large-cap optical networking; extreme event volatility. Classification: avoid-first, tactical bearish only after confirmation; short loss is unlimited. Direction highly uncertain.
Horizons: Day: observe $311.60–$358.76 range. 1–4 weeks: bearish only below $311.60 after failed reclaim. 3–12+ months: no short thesis; strong operating growth requires valuation/margin review.
Thesis/catalyst: $317.46, −10.36% on 7.52M shares versus 2.30M 20-session average despite Q3 revenue +37%, adjusted EPS +215% and raised FY26 revenue guidance. That divergence is a verified expectations warning.
Evidence / counterargument: close near $311.60 low and below prior $348.86 low. Counter: fundamentals and $1.75B ±$50M Q4 revenue guide are strong; a squeeze/reversal can be violent.
Entry/confirmation: avoid; tactical bearish only after failed $325–$330 reclaim then break below $311.60. Invalidation/downside: close above $330 weakens; above $358.76 invalidates. Key risks: squeeze, gaps, order timing, margins, customer concentration, valuation and unlimited short loss; borrow/fees unknown. release · price
Risk class: mega-cap semiconductor/infrastructure; leverage, concentration and event risk. Classification: avoid until reclaim; short only on breakdown. Direction uncertain; short loss unlimited.
Horizons: Day: watch $342.33–$359.40. 1–4 weeks: bearish only below $342.33. 3–12+ months: no short thesis until AI demand, VMware cash generation, debt and valuation are fully reviewed.
Thesis/catalyst: $357.16, −2.75% on 60.1M shares after strong Q3 results; it closed below the prior $364.65 weakness level. Official revenue was $29.591B, FCF $13.665B and AI-semiconductor revenue $16.7B, showing the bearish case is expectations/price—not business collapse.
Evidence / counterargument: volume was 2.7× the 20-session average and the low was $342.33. Counter: price recovered $14.83 off the low and Q4 AI revenue expectation is $21.7B, creating squeeze risk.
Entry/confirmation: avoid; bearish only after failed $359.40–$364.65 reclaim and loss of $342.33. Invalidation/downside: close above $364.65 weakens; above $371.09 invalidates. Key risks: AI upside, squeeze, concentration, VMware integration, debt, export controls, rates and unlimited short loss; borrow/fees unknown. release · price
Risk class: high-beta AI connectivity; concentration, valuation and extreme post-earnings risk. Classification: avoid-first; no blind short. Direction highly uncertain; short loss unlimited.
Horizons: Day: only observe $161.95–$171.13. 1–4 weeks: avoid until base or reclaim. 3–12+ months: requires customer mix, margins, valuation and FCF analysis—not a standing short.
Thesis/catalyst: $164.17, −0.64% while Nasdaq rose 1.40%, after Wednesday's −20.04%. It failed at $171.13 and closed near $164.11 low, confirming damaged relative strength but not a fresh breakdown.
Evidence / counterargument: the stock remains near the event low and below $190.57. Counter: Q2 revenue guide $525–535M and strong growth can drive a sharp reversal; Thursday never lost $161.95.
Entry/confirmation: avoid; bearish only after failed $171.13 reclaim and break below $161.95. Invalidation/downside: above $171.13 weakens; sustained reclaim above $190.57 invalidates. Key risks: squeeze, gaps, customer concentration, margins, valuation and unlimited loss; borrow/fees unknown. release · price
| Name / risk | Classification & horizons | Evidence / counterargument | Confirmation / invalidation | Scores C/R/O |
|---|---|---|---|---|
| Watch SNOW · Snowflake (NYSE) Large-cap cloud; event, valuation, SBC risk | Gap-hold watch. Day: opening range. 1–4w: above $355.47. 3–12m: only after GAAP/SBC/FCF valuation review. | $356.47, +16.55% on 21.8M vs 5.1M average; product revenue +37%, RPO +30%, FY guide raised. Counter: faded from $384.56; GAAP operating loss $263M. release | Confirm hold $355.47 then reclaim $370/$384.56. Close below $350 weakens; below $319.25 invalidates gap thesis. | 91 / 96 / 58 |
| Watch PLTR · Palantir (Nasdaq) Large-cap, high-multiple AI software | Failed-bear recovery. Day/1–4w: above $185.83. 3–12m: needs fresh valuation/fundamental review. | $182.53, +7.71%, closed above yesterday's $179.75 bearish invalidation; this explicitly cancels that tactical bear. Counter: below $185.83/$188.37 and no new primary catalyst verified. price | Confirm above $185.83 then $188.37. Below $171.91 invalidates recovery. | 76 / 94 / 51 |
| Watch IONQ · IonQ (NYSE) Speculative quantum; extreme dilution/duration risk | Speculative reclaim. Day/1–4w: only above $39.78. 3–12m: requires commercial/unit-economics proof. | $39.02, +3.67%; reclaimed the prior $38.24 first trigger but did not close above the $39.25 second trigger. Warrant dates are known. Counter: below $41.92 5-day high; economics not de-risked. 8-K | Confirm close above $39.78 then $41.92. Below $37.84 weakens; below $36.785 invalidates. | 82 / 99 / 43 |
| Watch NVO · Novo Nordisk ADR (NYSE) Large-cap peptide pharma; pipeline/pricing/ADR risk | Rebound watch. Day/1–4w: above $48.00. 3–12m: pipeline, reimbursement, manufacturing and valuation review. | $47.51, +1.58%, second gain; peptide group mixed. Counter: no fresh company catalyst verified and LLY competition is intense. price | Confirm above $48.00 then $48.66. Below $46.57 weakens; below $44.95 invalidates rebound. | 65 / 78 / 50 |
| Watch ORCL · Oracle (NYSE) Mega-cap cloud; earnings, capex, financing risk | Event watch only. Day/1–4w: wait for Sep. 8 results. 3–12m: backlog, cloud growth, capex/debt and valuation review. | Nasdaq lists Sep. 8 earnings; third-party EPS forecast $1.40 from 10 estimates is not company guidance and is not used as a target. AI-cloud read-through is important. Nasdaq | No pre-event price trigger asserted because a fresh ORCL chart was not part of today's verified idea set. Invalidation: do not trade solely on calendar/consensus. | 61 / 88 / 44 |
Scores are Thesis Confidence / Risk / Opportunity, all 0–100; higher Risk means riskier. Confidence measures evidence quality, never outcome probability. Levels are conditional, not claimed fills.
Bias: wait for 14:30 CEST payrolls; then favor only confirmed NVDA/HPE/VRT strength. Let ZS/IOT/DOCU/PATH establish ranges. Avoid chasing SNOW and bottom-fishing CIEN/CRDO.
Biggest risk: jobs revisions or Gulf/oil headline gaps. Invalidation: constructive bias fails if ES loses 7,754.75 settlement and NQ loses 29,524.75 while 10Y/oil rise.
Bias: selective risk-on; trail confirmations rather than add duration indiscriminately. Quantum remains watch-only; AI winners must hold breakout levels.
Biggest risk: CPI/FOMC reprice a still-high 4.77% 10Y upward. Invalidation: broad closes below Thursday's breakout levels plus VIX back above 15.20 cancel the upgrade.
Bias: favor profitable AI infrastructure only after valuation/FCF/debt work; require commercial proof in quantum and complete clinical/runway evidence in biotech.
Biggest risk: inflation/energy, capex digestion, concentration, dilution or failed endpoints. Invalidation: durable order/margin/FCF deterioration—not a single volatile session—would challenge the long-term AI thesis.